COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
BRAIN Biotech AG and AMSilk collaborate on protein engineering for performance materials, registering their first patent application. The strategic partnership aims for sustainable bio-based solutions in the textile industry -
-
-
COMMUNIQUÉ DE PRESSE
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026 -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026
